PAK (p21-activated kinase) inhibitors are critical in regulating cellular signaling pathways, often implicated in cancer and other diseases. By blocking PAK activity, these inhibitors modulate various cellular processes, such as cell motility and proliferation. Research on PAK inhibitors contributes to a deeper understanding of cell signaling, which can lead to novel therapeutic strategies in cancer treatment and other disorders.
